Israel’s health basket lists the services, medicines, and technologies the four health funds must provide. Each year, a public committee reviews proposals and recommends additions within the budget set for that year; the government approves the expansion.
The Ministry of Health invites proposals from hospitals, health funds, medical bodies, companies, patients, and patient organizations. The committee includes health professionals, government representatives, and public members with expertise in fields such as ethics and economics.
How the committee sets priorities
Committee members assess medical and clinical evidence, patient need, and the resources available. They consider the broad range of submitted technologies and medicines against the annual budget, then recommend which additions should be funded. The Ministry describes this as an effort to balance health needs and use limited resources effectively.
For the 2026 expansion, the committee began work with a NIS 650 million budget. On March 4, 2026, the government approved recommendations covering 650 medicines and technologies at a stated cost of NIS 86.45 million, expected to benefit about 107,000 people. Those are figures for that year, not a standing annual allocation.
What an addition means for patients
Basket additions identify approved medicines, technologies, uses, and eligibility conditions. Inclusion does not make a treatment available for every diagnosis or every patient; the approved indication and clinical criteria govern access.
Read the Ministry’s description of the public committee and its process and its health basket updates. The Knesset analysis of basket costs explains how basket financing fits the wider system. See also how the four health funds deliver coverage.